Also Known As
[Often referred to by brand name]
Formal Name
Cyclosporine
This article was last reviewed on
This article waslast modified on
April 24, 2018.
At a Glance
Why Get Tested?

To determine the concentration of cyclosporine in your blood in order to establish a dosing regimen, maintain therapeutic levels, and detect toxic levels

When To Get Tested?

As soon as cyclosporine therapy begins, usually daily or 2-3 times a week, and periodically after that as the dose is adjusted or maintained

Sample Required?

A blood sample drawn from a vein in your arm

Test Preparation Needed?

None. Typically drawn 12 hours after the last dose; on mornings when you are scheduled to have your cyclosporine level checked, do not take the medicine until after your blood is drawn.

You may be able to find your test results on your laboratory's website or patient portal. However, you are currently at Lab Tests Online. You may have been directed here by your lab's website in order to provide you with background information about the test(s) you had performed. You will need to return to your lab's website or portal, or contact your healthcare practitioner in order to obtain your test results.

Lab Tests Online is an award-winning patient education website offering information on laboratory tests. The content on the site, which has been reviewed by laboratory scientists and other medical professionals, provides general explanations of what results might mean for each test listed on the site, such as what a high or low value might suggest to your healthcare practitioner about your health or medical condition.

The reference ranges for your tests can be found on your laboratory report. They are typically found to the right of your results.

If you do not have your lab report, consult your healthcare provider or the laboratory that performed the test(s) to obtain the reference range.

Laboratory test results are not meaningful by themselves. Their meaning comes from comparison to reference ranges. Reference ranges are the values expected for a healthy person. They are sometimes called "normal" values. By comparing your test results with reference values, you and your healthcare provider can see if any of your test results fall outside the range of expected values. Values that are outside expected ranges can provide clues to help identify possible conditions or diseases.

While accuracy of laboratory testing has significantly evolved over the past few decades, some lab-to-lab variability can occur due to differences in testing equipment, chemical reagents, and techniques. This is a reason why so few reference ranges are provided on this site. It is important to know that you must use the range supplied by the laboratory that performed your test to evaluate whether your results are "within normal limits."

For more information, please read the article Reference Ranges and What They Mean.

What is being tested?

Cyclosporine is an immunosuppressant drug used to reduce the body's natural defenses. This test measures the amount of cyclosporine in the blood.

When people undergo an organ transplant, their immune system recognizes the graft as "foreign" and will begin to attack it just as it would any invasive bacteria or virus. Cyclosporine diminishes the ability of certain white blood cells in the immune system to respond to this foreign tissue. The transplanted organ then has a better chance of survival and will not be as easily rejected by the transplant recipient's immune system. Cyclosporine is used routinely in the transplantation of kidney, heart, liver, and other organs.

The immunosuppressant qualities of cyclosporine have also been found to be useful in treating symptoms of some autoimmune and other disorders. These conditions are characterized by the immune system reacting to the body's own cells or tissue. Cyclosporine helps to control the immune response in these cases, decreasing the severity of symptoms. Some examples of these conditions include rheumatoid arthritis, psoriasis, aplastic anemia, and Crohn disease.

When the symptoms in these cases are judged to be severe, extensive, and disabling, cyclosporine may be prescribed. Usually, the symptoms have not diminished with other treatments or medications. Cyclosporine is used with caution in these cases and needs to be carefully monitored with blood tests.

Testing cyclosporine levels in the blood can help ensure that drug levels are in a range that will be therapeutic. If the level is too low, organ rejection may occur (in the case of transplantation) or symptoms may reappear (autoimmune cases). It is also important to ensure that the level is not too high and will not result in toxicity.

How is the sample collected for testing?

A blood sample is obtained by inserting a needle into a vein in the arm.

Is any test preparation needed to ensure the quality of the sample?

No test preparation is needed. Samples are typically drawn 12 hours after the last dose. On mornings when someone is scheduled to have their cyclosporine level checked, the person should not take the medicine until after their blood is drawn.

Accordion Title
Common Questions
  • How is it used?

    Tests for cyclosporine are used to measure the amount of this drug in the blood to determine whether cyclosporine concentrations have reached therapeutic levels and are not in a toxic range. Cyclosporine is a drug that diminishes the body's immune response. It is prescribed for organ transplant recipients to prevent organ rejection and for some people with autoimmune conditions, such as rheumatoid arthritis, to alleviate symptoms.

    It is important to monitor levels of the drug for several reasons:

    • There is not a good correlation, as with some other medications, between the dose of cyclosporine given and level of drug in the blood.
    • Absorption and metabolism of oral doses of cyclosporine can vary greatly between people and even in the same person depending on the time of dose and what food is eaten.
    • There can be variation in blood levels due to the brand or preparation of cyclosporine prescribed.
    • In transplant patients, it is particularly important for graft survival to ensure that cyclosporine levels are high enough immediately following surgery to prevent rejection of the transplanted organ.
    • In the case of rheumatoid arthritis or psoriasis, blood levels of cyclosporine must be high enough to give relief of symptoms.
    • In the case of kidney transplantation, blood levels may help to distinguish between kidney rejection and kidney damage due to high levels of cyclosporine.
    • Cyclosporine is associated with several toxic side effects that can be avoided if blood levels are monitored. The dose may be adjusted if the detected level is too high.

    By monitoring cyclosporine blood levels, health practitioners can better ensure that each individual is receiving the right amount and formulation of drug needed to treat his or her particular case.

  • When is it ordered?

    Cyclosporine testing is ordered frequently at the start of therapy, often on a daily basis when trying to establish a dosing regimen. Once an appropriate dose has been determined, the level can be tested less frequently and may eventually be tested monthly, once every two months, or at longer intervals. However, testing may be done more often when a person becomes ill or begins taking additional medications that may affect the metabolism of cyclosporine. A change in a person's metabolic status may also prompt more frequent testing.

    Often in transplantation, people will begin with higher doses of cyclosporine at the start of therapy and then decrease the dose over the course of long-term therapy. In the cases of rheumatoid arthritis or psoriasis, if a person appears to tolerate the drug well, the dose may be increased to further improve symptoms.

    With each change in dose, blood levels need to be measured. In addition, the frequency of testing depends on a number of factors, including the medical reason for taking cyclosporine. In organ transplantation, the type of organ transplanted and the recipient's age and general health status will inform dosing. For example, a person with a transplanted liver may need to be monitored more often since cyclosporine is metabolized mainly by the liver and impaired function can slow clearance of cyclosporine from the blood.

    When organ rejection or kidney toxicity is suspected, tests may also be ordered more often. Some signs and symptoms of cyclosporine toxicity are:

    • Kidney damage
    • High blood pressure
    • Tremors
    • Bleeding, swelling, overgrowth of gums
    • Excess hair on the body and face (hirsutism)
    • High lipid levels in the blood (hyperlipidemia)
    • Low blood magnesium level
    • Jaundice, including yellow eyes, dark urine and/or pale stools
    • Nausea
  • What does the test result mean?

    The therapeutic range for cyclosporine depends on the method used to measure the drug, the type of transplant, and the length of time since the transplant. Results obtained from different types of samples and different methods are not interchangeable. Health practitioners will be guided by the laboratory as to the appropriate therapeutic range to apply to a specific person's test result.

    If trough levels fall below the desired range, there is a risk of transplant rejection or symptom recurrence. If levels detected are above the range, there is a risk of toxic side effects.

    Peak concentrations of samples collected 2 hours post-dose are sometimes tested in transplant cases. High levels of cyclosporine in peak samples are correlated with reduced rejection rates, especially in the first year after transplant surgery.

  • Is there anything else I should know?

    A majority of laboratories use whole blood samples for cyclosporine testing instead of serum or plasma and will collect samples 12 hours after the last dose or just before the next dose (trough levels). Some laboratory methods are more specific for the cyclosporine parent drug, while others measure the parent drug plus the metabolites, so their respective ranges will differ. Because cyclosporine therapeutic ranges can vary with type of assay performed by the laboratory, it is recommended that blood samples be tested by the same institution over the course of therapy. Results will be more consistent and will correlate better with the reported therapeutic range.

    For conditions other than transplants, cyclosporine may be prescribed with other medications, such as non-steroidal anti-inflammatory drugs (NSAIDs). In transplant cases, other anti-rejection drugs may be used along with cyclosporine. These drugs will work in conjunction to treat a person's condition. In addition, cyclosporine blood levels can be affected by other medications a person may be taking. It is important for health practitioners to be are aware of what medications and supplements their patients are taking and to be notified of changes in diet or health status that may affect cyclosporine concentrations.

    Several prescription drugs can interact dangerously with cyclosporine and should not be taken at the same time. Tell your health care provider about all the medications you are taking.

    Cyclosporine may cause high blood pressure and kidney damage. Tell your health care provider if you have or have ever had high blood pressure or kidney disease. Health practitioners may order additional laboratory tests to detect high lipid levels or to monitor kidney and liver function.

    Avoid grapefruit juice. It slows the body's normal breakdown of cyclosporine, allowing it to build up to potentially excessive levels in the blood, and can maintain this effect in the body for three days or more following the last glass of juice. Your health care provider might tell you to limit the amount of potassium in your diet and may advise you to limit potassium-rich foods.

  • How long will I need to be on cyclosporine?

    If you are a transplant recipient, you generally will stay on cyclosporine as long as that is the treatment of choice for you. If there are signs of rejection, even with blood levels in the therapeutic range, you may be switched to a different immunosuppressant drug. Also, there is a greater chance of toxic side effects the longer you are on cyclosporine, so a health practitioner may choose to alter drug therapy when you have been on cyclosporine for more than 2-3 years.

    If you have an autoimmune disorder such as rheumatoid arthritis, Crohn disease, or psoriasis, you will be treated with cyclosporine only when your symptoms are acute and if other treatments have not been effective. It is not advised that your stay on cyclosporine for more than a year due to an increase in the likelihood of toxic symptoms the longer you are on the medication. Short-term or intermittent courses of 12 weeks at a time are more advisable.

  • Who orders cyclosporine tests?

    Cyclosporine will usually be monitored by health practitioners who have specific knowledge of the condition or disease for which the drug is prescribed. They tend to be very familiar with cyclosporine and its use in therapy, and they understand the importance of monitoring the drug. They may include your surgeon or your doctor treating you for your arthritis or psoriasis.

View Sources

Sources Used in Current Review

Henry's Clinical Diagnosis and Management by Laboratory Methods. 22nd ed. McPherson R, Pincus M, eds. Philadelphia, PA: Saunders Elsevier: 2011, Pp 354-355.

Cyclosporine. University of Washington Medical Center. Available online at https://healthonline.washington.edu/document/health_online/pdf/Heart-Transplant-Cyclosporine.pdf through https://healthonline.washington.edu. Last reviewed October 2012. Accessed October 21, 2013.

Cyclosporine. Medline Plus. Available online at http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601207.html through http://www.nlm.nih.gov. Last updated September 1, 2010. Accessed October 21, 2013.

Cyclosporine. NYU Langone Medical Center. Available online at http://www.med.nyu.edu/content?ChunkIID=21718 through http://www.med.nyu.edu. Last reviewed August 2013. Accessed November 1, 2013.

Cyclosporine Clinic Guidelines for Monitoring Physicians. Vancouver Coastal Health. Avaialble online at http://www.arthritis.ca/document.doc?id=555 through http://www.arthritis.ca. Last reviewed April 2012. Accessed November 1, 2013.

(Updated Nov 17, 2011) Pelligrino B. Immunosuppression. Medscape Reference article. Available online at http://emedicine.medscape.com/article/432316-overview through http://emedicine.medscape.com. Accessed November 2013.

Sources Used in Previous Reviews

A Manual of Laboratory & Diagnostic Tests. 6th ed. Fischbach F, ed. Philadelphia: Lippincott Williams & Wilkins; 2000.

Clinical Chemistry: Principles, Procedures, and Correlations. Bishop M, Duben-Engelkirk J, Fody E, eds. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2000.

Clinical Diagnosis and Management by Laboratory Methods. 20th ed. Henry JB, ed. New York: Saunders: 2001.

Sacher RA, McPherson RA, Campos J. Widmann's Clinical Interpretation of Laboratory Tests. 11th ed. Philadelphia: F.A. Davis Company; 2000.

Karen L. Hardinger, Pharm.D. Matthew J. Koch, M.D.; Daniel C. Brennan, M.D., FACP (Posted 10/01/2004) Current and Future Immunosuppressive Strategies in Renal Transplantation, Medscape from Pharmacotherapy. Available online at http://www.medscape.com/viewarticle/489357 through http://www.medscape.com.

TOXNET, Toxicology Data Network (April 2006). Hazardous Substance Database. Division of Specialized Information Services (SIS) of the National Library of Medicine (NLM) (Online information-Search cyclosporine). Available online at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB through http://toxnet.nlm.nih.gov.

Medscape detailed monograph: Oral Cyclosporine (April 2006). Available online through http://www.medscape.com.

Michael R. Lucey; Manal F. Abdelmalek; Rosemarie Gagliardi; Darla Granger; Curtis Holt; Igal Kam; Goran Klintmalm; Alan Langnas; Kirti Shetty; Andreas Tzakis; E. Steve Woodle (2005). A Comparison of Tacrolimus and Cyclosporine in Liver Transplantation: Effects on Renal Function and Cardiovascular Risk Status. Medscape from American Journal of Transplantation 5(5):1111-1119. Available online at http://www.medscape.com/viewarticle/503095 through http://www.medscape.com.

Well, G (2005). Cyclosporine for treating rheumatoid arthritis. Cochrane Rev Abstract, The Cochrane Collaboration. Available online at http://www.medscape.com/viewarticle/485484 through http://www.medscape.com.

Naldi, L., Griffiths, CEM (2005). Traditional Therapies in the Management of Moderate to Severe Chronic Plaque Psoriasis: An Assessment of the Benefits and Risks. British Journal of Dermatology 152(4): 597-615. Available online at http://www.medscape.com/viewarticle/503441 through http://www.medscape.com.

(Revised 2009 December 1). Cyclosporine. MedlinePlus Drug Information [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601207.html. Accessed March 2010.

McMillin, G., and Wittwer, C. (Updated 2009 August). Organ Transplantation - Immunosuppressive Drugs. ARUP Consult [On-line information]. Available online at http://www.arupconsult.com/Topics/ImmunosuppressiveDrugs.html?client_ID=LTD through http://www.arupconsult.com. Accessed March 2010.

Pellegrino, B. and Schmidt, R. (Update 2009 October 14). Immunosuppression. eMedicine [On-line information]. Available online at http://emedicine.medscape.com/article/432316-overview through http://emedicine.medscape.com. Accessed March 2010.

Malhotra, P. et. al. (Updated 2009 July 28). Immunology of Transplant Rejection. eMedicine [On-line information]. Available online at http://emedicine.medscape.com/article/432209-overview through http://emedicine.medscape.com. Accessed March 2010.

(Updated 2010 March 1). Cyclosporine (Oral Route, Intravenous Route). MayoClinic.com [On-line information]. Available online at http://www.mayoclinic.com/health/drug-information/DR601591 through http://www.mayoclinic.com/. Accessed March 2010.

Clarke, W. and Dufour, D. R., Editors (© 2006). Contemporary Practice in Clinical Chemistry: AACC Press, Washington, DC. Pp 462.

Wu, A. (© 2006). Tietz Clinical Guide to Laboratory Tests, 4th Edition: Saunders Elsevier, St. Louis, MO. Pp 1326-1329.

Ask a Laboratory Scientist

 

Your questions will be answered by a laboratory scientist as part of a voluntary service provided by one of our partners, the American Society for Clinical Laboratory Science (ASCLS). Click on the Contact a Scientist button below to be re-directed to the ASCLS site to complete a request form. If your question relates to this web site and not to a specific lab test, please submit it via our Contact Us page instead. Thank you.

Contact a Scientist